BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29848352)

  • 21. Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.
    Zhou CJ; Zhang QH; Zhang TG; Sun SZ; Li H; Wang Y; Liu ZY
    Pathol Oncol Res; 2009 Jun; 15(2):153-8. PubMed ID: 18941930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
    Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
    Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
    Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.
    Zhao X; Mirza S; Alshareeda A; Zhang Y; Gurumurthy CB; Bele A; Kim JH; Mohibi S; Goswami M; Lele SM; West W; Qiu F; Ellis IO; Rakha EA; Green AR; Band H; Band V
    Breast Cancer Res Treat; 2012 Jul; 134(1):171-80. PubMed ID: 22270930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.
    Zhao H; Yang M; Zhao J; Wang J; Zhang Y; Zhang Q
    Med Oncol; 2013 Mar; 30(1):475. PubMed ID: 23371253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.
    dos Santos PB; Zanetti JS; Ribeiro-Silva A; Beltrão EI
    Diagn Pathol; 2012 Aug; 7():104. PubMed ID: 22894137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications.
    Liu C; Zhang H; Shuang C; Lu Y; Jin F; Xu H; Lu P
    Med Oncol; 2010 Sep; 27(3):747-52. PubMed ID: 19657752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression.
    Logullo AF; Nonogaki S; Pasini FS; Osório CA; Soares FA; Brentani MM
    Oncol Rep; 2010 Feb; 23(2):313-20. PubMed ID: 20043090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
    Takagi K; Miki Y; Nakamura Y; Hirakawa H; Kakugawa Y; Amano G; Watanabe M; Ishida T; Sasano H; Suzuki T
    Histol Histopathol; 2015 Oct; 30(10):1223-32. PubMed ID: 25873048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F; Wang L; Zhang W; Lyu S; Niu Y
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
    Hanley K; Wang J; Bourne P; Yang Q; Gao AC; Lyman G; Tang P
    Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
    Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
    Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.
    Tsuchiya B; Iwaya K; Kohno N; Kawate T; Akahoshi T; Matsubara O; Mukai K
    Histopathology; 2012 Jul; 61(1):69-77. PubMed ID: 22385318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
    Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
    Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
    Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
    Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer.
    Koo JS; Park S; Kim SI; Lee S; Park BW
    Tumour Biol; 2011 Aug; 32(4):787-99. PubMed ID: 21584795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.